# Contact Legit NAD: NAD+ Editorial Corrections and Questions

> Contact the Legit NAD editorial project about the NAD+ research digest - corrections, citation questions and feedback. We do not sell products or provide medical advice.

Corrections, citation questions and feedback on the NAD+ digest. Not a clinic, not a vendor, no medical advice.

## Reach the editorial desk

This project covers the NAD+ research literature as an editorial digest. Use the form to send a correction, ask about a citation, flag a study we should include, or share feedback on how a finding is graded. We read everything, and we prioritize correcting any claim that does not match its source.

## What we cannot help with

We cannot give medical advice, recommend a dose, suggest a product or brand, or advise on whether NAD+, NMN, NR or IV NAD+ is appropriate for you - those are questions for a qualified clinician who knows your history. We do not sell, compound, prescribe, or ship anything, and we have no commercial relationship with any supplement seller. For dosing and safety, the [tolerability and safety](/faq) page reports only what the studies measured, never a personal recommendation.

## Corrections policy

Accuracy is the whole point of a due-diligence digest. If a number, citation or tier on the site is wrong, tell us what and where, and we will check it against the primary source and fix or retract it. We would rather mark a gap than overstate a finding, and a correction that tightens the evidence record is always welcome.

---

A due-diligence console for the NAD+ literature - oral-precursor trials graded established, poorly-absorbed oral NAD+ and rapidly-cleared IV infusions held apart, and the contested NMN supplement status read as filed; no clinic behind the readout and nothing here dosed, prescribed, or sold.